Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerosis
multiple sclerosis
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tue, 05/25/10 - 09:02 am
FDA
Novartis
MS
multiple sclerosis
Gilenia
FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
WSJ Online
Thu, 05/13/10 - 10:38 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Mon, 04/19/10 - 10:57 am
Novartis
multiple sclerosis
MS
Biogen Idec
Merck
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Fri, 04/16/10 - 11:16 am
Genzyme
cancer
MS
multiple sclerosis
Campath
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thu, 04/15/10 - 09:58 am
MS
multiple sclerosis
Campath
Carl Icahn
Genzyme
Genzyme sees MS drug topping efficacy league
Reuters
Wed, 04/14/10 - 01:59 pm
Genzyme
Campath
multiple sclerosis
MS
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Novartis
MS
multiple sclerosis
Gilenia
Abbott a Step Closer to FACT
Yahoo/Zacks
Sat, 04/10/10 - 12:10 pm
Abbott Laboratories
Facet Biotech
daclizumab
multiple sclerosis
Biogen Idec
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Fri, 04/9/10 - 07:52 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen, Merck, Bayer MS Drugs Targeted by Test Predicting Which Ones Work
Bloomberg
Mon, 03/29/10 - 10:09 am
Biogen Idec
Merck
Bayer
MS
multiple sclerosis
New Insight Into Multiple-Sclerosis Treatment (beta -interferon)
Wall Street Journal
Sun, 03/28/10 - 01:11 pm
multiple sclerosis
beta-interferon
Acorda applies to extend Ampyra patent protection
Yahoo/AP
Mon, 03/22/10 - 09:54 am
Acorda Therapeutics
patents
AMPYRA
MS
multiple sclerosis
Stronger Label for Biogen's Tysabri
Yahoo/Zacks.com
Mon, 03/1/10 - 10:00 am
Biogen Idec
Elan
Tysabri
multiple sclerosis
Copaxone 15-Year Study In Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy And Safety
Medical News Today
Sun, 02/28/10 - 01:08 pm
Copaxone
multiple sclerosis
Teva Pharmaceuticals
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wed, 02/17/10 - 09:01 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:37 am
Teva Pharmaceuticals
Active Biotech
partnerships
MS
multiple sclerosis
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Wed, 01/27/10 - 10:57 am
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
Mon, 01/25/10 - 12:36 pm
MS
multiple sclerosis
Biogen Idec
FDA
AMPYRA
What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)
Wall Street Journal
Sat, 01/23/10 - 10:52 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
next ›
last »